You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ELOCON Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Elocon, and when can generic versions of Elocon launch?

Elocon is a drug marketed by Organon and is included in three NDAs.

The generic ingredient in ELOCON is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Elocon

A generic version of ELOCON was approved as mometasone furoate by PADAGIS US on March 18th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ELOCON?
  • What are the global sales for ELOCON?
  • What is Average Wholesale Price for ELOCON?
Summary for ELOCON
US Patents:0
Applicants:1
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 79
Clinical Trials: 3
Patent Applications: 5,129
Drug Prices: Drug price information for ELOCON
What excipients (inactive ingredients) are in ELOCON?ELOCON excipients list
DailyMed Link:ELOCON at DailyMed
Drug patent expirations by year for ELOCON
Drug Prices for ELOCON

See drug prices for ELOCON

Recent Clinical Trials for ELOCON

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
LEO PharmaPhase 1
University of OuluPhase 4
Merck Sharp & Dohme Corp.Phase 4

See all ELOCON clinical trials

Paragraph IV (Patent) Challenges for ELOCON
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ELOCON Topical Solution (Lotion) mometasone furoate 0.1% 019796 1 2004-06-10

US Patents and Regulatory Information for ELOCON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon ELOCON mometasone furoate CREAM;TOPICAL 019625-001 May 6, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organon ELOCON mometasone furoate OINTMENT;TOPICAL 019543-001 Apr 30, 1987 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organon ELOCON mometasone furoate CREAM;TOPICAL 019625-002 Apr 19, 2013 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ELOCON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon ELOCON mometasone furoate LOTION;TOPICAL 019796-001 Mar 30, 1989 ⤷  Sign Up ⤷  Sign Up
Organon ELOCON mometasone furoate CREAM;TOPICAL 019625-001 May 6, 1987 ⤷  Sign Up ⤷  Sign Up
Organon ELOCON mometasone furoate LOTION;TOPICAL 019796-001 Mar 30, 1989 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ELOCON

See the table below for patents covering ELOCON around the world.

Country Patent Number Title Estimated Expiration
Hong Kong 68487 AROMATIC HETEROCYCLIC ESTERS OF STEROIDS,THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ⤷  Sign Up
New Zealand 199600 17-(HETEROCYCLIC CARBOXYLATE)-SUBSTITUTED STEROIDS ⤷  Sign Up
Japan S6360036 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ELOCON

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3043773 21C1057 France ⤷  Sign Up PRODUCT NAME: MOMETASONE OU L'UN DE SES SELS AVEC OLOPATADINE OU L'UN DE SES SELS; NAT. REGISTRATION NO/DATE: NL52121 20211026; FIRST REGISTRATION: AT - 140638 20210426
3043773 2022C/520 Belgium ⤷  Sign Up PRODUCT NAME: MOMETASONE OF EEN ZOUT HIERVAN EN OLOPATADINE OF EEN ZOUT HIERVAN; AUTHORISATION NUMBER AND DATE: BE595626 20220203
0057401 94C0003 Belgium ⤷  Sign Up PRODUCT NAME: MOMETASONI FUROAS; NAT REG.: 304 S 132 F 11 19930813; FIRST REG.: GR 10683/89 19900622
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.